Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. (Q40120849)

17 September 2017

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. (English)

1 reference

17 September 2017

cognitive dysfunction

1 reference

1

Martin Dichgans

1 reference

17 September 2017

Hugh S Markus

2

1 reference

17 September 2017

Stephen Salloway

3

1 reference

17 September 2017

Auli Verkkoniemi

4

1 reference

17 September 2017

Margaret Moline

5

1 reference

17 September 2017

Qin Wang

6

1 reference

17 September 2017

Holly Posner

7

1 reference

17 September 2017

Hugues S Chabriat

8

1 reference

17 September 2017

language of work or name

1 reference

28 February 2008

1 reference

17 September 2017

1 reference

17 September 2017

7

1 reference

17 September 2017

4

1 reference

17 September 2017

310-318

1 reference

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Cholinergic denervation in a pure multi-infarct state: observations on CADASIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Cholinergic neuronal deficits in CADASIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Subcortical ischaemic vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Donepezil in vascular dementia: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Galantamine treatment of vascular dementia: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

General measures of cognition.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

The cognitive profiles of CADASIL and sporadic small vessel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

1 reference

7 January 2021

Patterns of MRI lesions in CADASIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Bedside assessment of executive cognitive impairment: the executive interview

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

CLOX: an executive clock drawing task

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Why do frontal lobe symptoms predominate in vascular dementia with lacunes?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Frontal systems impairment following multiple lacunar infarcts.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

Loss of cholinergic pathways in vascular dementia of the Binswanger type.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970046-2

7 January 2021

10.1016/S1474-4422(08)70046-2

Identifiers

DOI

1 reference

17 September 2017

1 reference